Inhibitory effect of melatonin on 7,12-dimethylbenz[a]anthracene-induced carcinogenesis of the uterine cervix and vagina in mice and mutagenesis in vitro

Cancer Letters

Volumn 156, Issue 2, 2000, Pages 199-205

  Anisimov, Vladimir N ^a   Zabezhinski, Mark A ^a   Popovich, Irina G ^a   Zaripova, Elena A ^a   Musatov, Sergey A ^a   Andre, Véronique ^b,c   Vigreux, Carole ^b,c   Godard, Thierry ^b,c   Sichel, François ^b,c  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b UNIVERSITÉ DE CAEN   (France)

^c CENTRE FRANÇOIS BACLESSE   (France)

Author keywords

7,12 Dimethylbenz a anthracene; Ames test; Carcinogenesis; COMET assay; DNA damage; Melatonin; Mouse; Single cell gel electrophoresis assay; Uterine cervix; Vagina

Indexed keywords

ANTIMUTAGENIC AGENT; DIMETHYLBENZ[A]ANTHRACENE; MELATONIN;

AMES TEST; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; FEMALE; IN VITRO STUDY; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX; UTERINE CERVIX CANCER; VAGINA; VAGINA CANCER;

SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0034637710     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00463-8     Document Type: Article

References (26)

1. M.P. Coleman J. Esteve P. Damiecki A. Arsalan H. Renard Trends in Cancer Incidence and Mortality 1993 IARC Sci. Publ. N 121, Lyon 806
2. M.T. Ruffin W.D. Lancaster Clinical models of chemoprevention for cervical cancer Hematol. Oncol. Clin. North Am. 12 1998 1115 1134
3. L. Tomatis Cancer: Causes, Occurence and Control. IARC Sci. Publ. No. 100, IARC, Lyon 1990 352
4. V.S. Turusov U. Mohr Pathology of tumours in laboratory animals. Vol. 2, Tumours of the Mouse, 2nd ed., IARC Sci. Publ. No. 111 1994 IARC Lyon 776
5. N.I. Volfson Genesis of Cancer of Cervix Uteri and Vagina (Experimental Study) Meditsina, Leningrad 1970 176
6. V.A. Alexandrov V.G. Bespalov A.S. Petrov S.S. Avtushenko The inhibitory effect of a water-soluble and liposomal beta-carotene on various models of carcinogenesis Vopr. Onkol. 44 1998 79 85
7. V.G. Bespalov V.A. Alexandrov D.N. Troian M. Yu Lidak The inhibiting effect of ortofen and dexamethasone on development of tumors of the cervix uteri and vagina Pharmacol. Toxicol 53 4 1990 49 51
8. IARC Handbooks of Cancer Prevention. Vol. 2., Carotenoids, IARC, Lyon, 1998, pp.326.
9. D.E. Blask Melatonin in oncology H.S. Yu R.J. Reiter Melatonin Biosynthesis, Physiological Effects, and Clinical Applications 1993 CRC Press Boca Raton, FL 447
10. M. Karasek Relationship between the pineal gland and experimentally induced malignant tumors G.J.M. Maestroni A. Conti R.J. Reiter Therapeutic Potential of Melatonin 1997 Front. Horm. Res., Basel, Karger 99 106
11. S.A. Musatov V.N. Anisimov V. Andre C. Vigreux T. Godard P. Sichel Effects of melatonin on N-nitroso-N-methylurea-induced carcinogenesis in rats and mutagenesis in vitro (Ames test and COMET assay) Cancer Lett. 138 1999 37 44
12. A. Subramanian L.S. Kothari Melatonin, a suppressor of spontaneous murine mammary tumors J. Pineal Res. 10 1991 136 140
13. F. Deerberg C. Bartsch G. Pohlmeyer H. Bartsch Effect of melatonin and physiological epiphysectomy on the development of spontaneous endometrial carcinoma in BDII/HAN rats Cancer Biother. Radiopharmacol. 12 1997 420
14. V.N. Anisimov I.G. Popovich M.A. Zabezhinski Melatonin and colon carcinogenesis: I Inhibitory effects of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats Carcinogenesis 18 1997 1549 1553
15. R.J. Reiter Experimental observations related to the utility of melatonin in attenuating age-related diseases Adv. Gerontol. 3 1999 121 132
16. R.J. Reiter D. Melchiorri E. Sewerinek B. Poegeller L. Barlow-Walden J. Chuang G.G. Ortiz D. Acuna-Castroviejo review of the evidence supporting melatonin's role as an antioxidant J. Pineal Res. 18 1995 1 11
17. S.A. Musatov V.N. Anisimov V. Andre C. Vigreux T. Godard P. Gauduchon F. Sichel Modulatory effects of melatonin on genotoxic response of reference mutagens in the Ames test and the comet assay Mutat. Res. 417 1998 75 84
18. N. Susa S. Ueno Y. Furukawa J. Ueda M. Sugiyama Potent protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes, Toxicol Appl. Pharmacol. 144 1997 377 384
19. D.X. Tan R.J. Reiter L.D. Chen B. Poeggeler L.C. Manchester L.R. Barlow-Walden Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole Carcinogenesis 15 1994 215 218
20. Vijayalaxmi R.J. Reiter M.L. Meltz Melatonin protects human blood lymphocytes from radiation-induced chromosome damage Mutation Res. 346 1995 23 31
21. D.M. Maron B.N. Ames Revised methods for the Salmonella mutagenicity test B.J. Kilbey M.S. Legator W. Nochols C. Ramel Handbook of Mutagenicity Test Procedures 1984 Elsevier Amsterdam 93 140
22. M.P. De Meo S. Mrono A.D. DeBaille A. Botta M. Laget H. Guiraud G. Dumenil Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials Int. Arch. Occup. Environ. Health 66 1995 363 368
23. V.J. McKelvey-Martin M.H.L. Green P. Schmezer B.L. Pool-Zobel M.P. De Meo A. Collins The single cell gel electrophoresis assay (comet assay): A European review Mutat. Res. 288 1993 47 63
24. E.V. Goubler Calculating Methods of Analysis and Identification of Pathological Processes 1978 Meditsina Moscow 296
25. R. Koratkar A. Vasudha G. Ramesh M. Padma U.N. Das Effect of melatonin on cis-platinum induced genetic damage to the bone marrow cells of mice Med. Sci. Res. 20 1992 179 180
26. L. Kothari A.A. Subramanian A possible modulatory influence of melatonin on representative phase I and II drug metabolizing enzymes in 9,10-dimethyl-1,2-benzanthracene induced rat mammary tumorigenesis Anti-Cancer Drugs 3 1992 623 628